As editor-in-chief of ACCP's new journal, JACCP, it is my pleasure to give you a glimpse of the plans we have for it. First, I want to make it clear how different JACCP will be from Pharmacotherapy. Although JACCP will mirror Pharmacotherapy's quality of manuscripts and reading audience, the scope of the manuscripts will differ significantly. Pharmacotherapy will continue to focus on human pharmacology and drug therapy, whereas JACCP will publish papers across the spectrum of clinical pharmacy practice. This will include original research and review articles on practice-based implementation science, innovations in practice, medication optimization and patient outcomes, economic outcomes, clinical pharmacy education and training, international clinical pharmacy practice, health care policy influencing clinical pharmacists, and care delivery models. Second, we hope that JACCP will provide a forum for discussion and debate about clinical pharmacy issues, often through editorials and letters to the editor. To be clear, JACCP will be completely dedicated to the discipline of clinical pharmacy practice and factors that affect it.
It is entirely appropriate that we also publish official ACCP statements and papers, ACCP poster abstracts, and Board of Pharmacy Specialties recertification modules. These are essential components for many clinical pharmacists practicing at the top of their training.
As a scientific editor for Pharmacotherapy for more than a decade, I can appreciate that it takes a team to publish a journal. I am thrilled to have three associate editors on my team: Robert Parker at the University of Tennessee, Beth Bryles Phillips at the University of Georgia, and Alan Zillich at Purdue University. Together, we are assembling an editorial board that will be committed to producing a journal that will benefit you in your clinical pharmacy practice. We anticipate introducing the editorial board to you soon.
JACCP will be online only and distributed to ACCP members with no increase in membership dues. We will begin taking submissions in January 2018. We look forward to receiving your best work!